Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.

Comirnaty targets the KP.2 subvariant of Omicron, replacing the previous version which targeted the XBB.1.5 subvariant ...

Pfizer-BioNTech's updated vaccine to protect against a recently circulating variant of COVID-19 is authorized, Health Canada ...

Pfizer and BioNTech said drug regulator Health Canada approved their updated Covid-19 vaccine, which will be available in the coming weeks.

The NHS is offering autumn Covid boosters to the most vulnerable in October. Many pharmacies also now sell the Covid jab ...

The Centers for Disease Control recommends everyone 6 months or older get a 2024-2025 COVID vaccine. The Food and Drug ...

While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union ...